tradingkey.logo

Rapid Micro Biosystems Inc

RPID

3.465USD

+0.155+4.68%
Horário de mercado ETCotações atrasadas em 15 min
151.39MValor de mercado
PerdaP/L TTM

Rapid Micro Biosystems Inc

3.465

+0.155+4.68%
Mais detalhes de Rapid Micro Biosystems Inc Empresa
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Informações da empresa
Código da empresaRPID
Nome da EmpresaRapid Micro Biosystems Inc
Data de listagemJul 15, 2021
CEOMr. Robert (Rob) Spignesi
Número de funcionários163
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 15
Endereço25 Hartwell Avenue
CidadeLEXINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02421
Telefone19783493200
Sitehttps://www.rapidmicrobio.com/
Código da empresaRPID
Data de listagemJul 15, 2021
CEOMr. Robert (Rob) Spignesi
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Product revenue
4.10M
56.92%
Service revenue
3.10M
43.08%
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.03M
28.12%
Switzerland
1.48M
20.54%
Germany
1.31M
18.17%
All other countries
1.27M
17.57%
Japan
1.12M
15.60%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product revenue
4.10M
56.92%
Service revenue
3.10M
43.08%
Distribuição de ações
Atualizado em: ter, 29 de jul
Atualizado em: ter, 29 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Bain Capital Life Sciences Investors, LLC
21.44%
Kennedy Lewis Investment Management LLC
12.56%
Longitude Capital Management Co., LLC
9.05%
Endeavour Medtech Growth II LP
5.74%
Ally Bridge Group (HK) Limited
4.70%
Other
46.51%
Investidores
Investidores
Proporção
Bain Capital Life Sciences Investors, LLC
21.44%
Kennedy Lewis Investment Management LLC
12.56%
Longitude Capital Management Co., LLC
9.05%
Endeavour Medtech Growth II LP
5.74%
Ally Bridge Group (HK) Limited
4.70%
Other
46.51%
Tipos de investidores
Investidores
Proporção
Investment Advisor
37.17%
Venture Capital
9.05%
Investment Advisor/Hedge Fund
7.59%
Corporation
5.74%
Individual Investor
5.39%
Hedge Fund
4.77%
Private Equity
1.47%
Pension Fund
0.28%
Other
28.55%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
67
28.04M
71.28%
+1.94M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
2023Q2
163
30.56M
83.28%
-10.69M
2023Q1
166
31.93M
87.35%
-8.18M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Bain Capital Life Sciences Investors, LLC
8.43M
21.44%
--
--
Mar 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.56%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
9.05%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.74%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.7%
+810.00K
+78.01%
Mar 31, 2025
Schonfeld Strategic Advisors LLC
1.03M
2.62%
+1.03M
--
Mar 31, 2025
Spignesi (Robert G JR)
872.37K
2.22%
+220.31K
+33.79%
Apr 07, 2025
The Vanguard Group, Inc.
890.28K
2.26%
+169.15K
+23.46%
Mar 31, 2025
Parkman Healthcare Partners LLC
735.62K
1.87%
+735.62K
--
Mar 31, 2025
Advent International L.P.
577.78K
1.47%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.02%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporção0.02%
Avantis US Small Cap Equity ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI